Accepted at 6:07 p.m. Oct, 26, 2023 by Cameron
Author: epcase
Co-authors: Cameron
Related Note: 1478995216607
Rationale for change

Added "Besides anti-malarials, anti-TBs, or NSAIDs" to clarify question (these are all contraindicated).

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid

Sketchy

Watch G6PD Deficiency & Autoimmune Hemolytic Anemia (AIHA)


Watch Pentose Phosphate Pathway & G6PD Deficiency
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize

Review G6PD Deficiency
Physeo
Bootcamp
Watch associated Bootcamp video - Normocytic Anemia: G6PD Deficiency

Watch associated Bootcamp video - Oxidative Stress: Pentose Phosphate Pathway: Uses of NADPH and Clinical Implications

Watch associated Bootcamp video - Antiparasitics: Chloroquine-Resistant and Exo-Erythrocytic Antimalarials

Watch associated Bootcamp video - Antiparasitics: Pyrimethamine, Sulfadiazine, Nitroimidazoles, and Intraluminal Agents
OME

Additional Resources
Other:


most erythrocytes with severe G6PD deficiency are hemolyzed early during the acute episodes, thus the G6PD assay may initially be abnormally normal; it is best to wait 3 months after the episode before re-testing

One by one
Empty field
#AK_Step2_v12::#Resources_by_rotation::IM::uw::heme/onc::heme/onc_zanki #AK_Step1_v12::#Physeo::05_Biochem::05_Metabolism::12_HMP_Shunt #AK_Step2_v12::Original_decks::Zanki_Step_2::IM::HemeOnc #AK_Step1_v12::#UWorld::Step::6562 #AK_Step1_v12::#Pixorize::01_Biochemistry::03_Metabolic_Disorders::04_G6PD_Deficiency #PANCE::EOR::PEDS #AK_Step1_v12::#FirstAid::01_Biochem::06_Metabolism::17_Glucose-6-phosphate_dehydrogenase_deficiency::*G6PD_Deficiency #AK_Step1_v12::#Pathoma::05_RBC::06_Normocytic_Anemias_with_Intravascular_Hemolysis #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::04_Pathology::11_Intrinsic_hemolytic_anemias::*G6PD_Deficiency #AK_Step1_v12::#Bootcamp::Microbiology::38_Antiparasitics::01_Pyrimethamine_Sulfadiazine_Nitroimidazoles_and_Intraluminal_Agents #AK_Step1_v12::#SketchyBiochem::01_Metabolism::01_Carbohydrates::13_Pentose_Phosphate_Pathway_&_G6PD_Deficiency #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::04_Normocytic_Anemia::06_G6PD_Deficiency #AK_Step1_v12::#Physeo::11_Pathology::10_HemeOnc_Pathology::08_Hemolytic_Anemia_Intrinsic_Causes #AK_Step1_v12::#AMBOSS::5aaiOQ #AK_Step1_v12::#Bootcamp::Microbiology::38_Antiparasitics::04_Chloroquine-Resistant_and_Exo-Erythrocytic_Antimalarials #AK_Step2_v12::#Resources_by_rotation::IM::uw::heme/onc::heme/onc_dorian #AK_Step2_v12::#Resources_by_rotation::Peds::nbme::form_8 #AK_Step1_v12::#OME::Clinical::04_Organ_Systems::05_Hematology_Oncology::02_Anemia::07_Normocytic_Anemia #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step2_v12::Original_decks::Dorian::im::uw::heme/onc #AK_Step1_v12::#B&B::13_Infectious_Disease::05_Parasites_and_Helminths::01_Malaria::Extra !AK_UpdateTags::Step1decks::Zanki-Step-Decks::Zanki-Hematology-&-Oncology::Pathoma-RBC #PANCE::GI::metabolic_disorders #AK_Step1_v12::#Bootcamp::Biochemistry::07_Oxidative_Stress::02_Pentose_Phosphate_Pathway:_Uses_of_NADPH_and_Clinical_Implications #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_RBC #AK_Step1_v12::^Systems::HemeOnc::RBC #AK_Step1_v12::#SketchyPath::09_Blood_&_Coagulation::02_Normocytic_&_Macrocytic_Anemias::03_G6PD_Deficiency_&_Autoimmune_Hemolytic_Anemia_(AIHA) #AK_Step1_v12::#OME::04_Organ_Systems::05_Hematology_Oncology::02_Anemia::07_Normocytic_Anemia #AK_Step1_v12::#Physeo::^physeo_image_update